Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.251ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.251ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.251NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCJORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCJENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCJNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FT.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FT.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FZ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.109ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.109ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.109ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.109NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.361ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.361ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.361ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.361NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.417ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.417ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.417ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.417NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AM.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.319ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.319ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used